Psychopharmacology
Psychopharmacology is a subscription (hybrid open access) journal published by Springer Science+Business Media in Germany. OpenAlex counts 18,513 works from it, cited 1,009,859 times; its h-index is 304. Its two-year mean citedness, which is computed the way the impact factor is, is 4.17: a paper it published in the two years before was cited about 4.17 times last year. It published 252 papers in 2025, up 15% from 219 in 2024. Publishing a paper open access in it costs about US$4,390.
- Publisher
- Springer Science+Business Media
- Citations per paper
- 4.17 two-year mean, OpenAlex
- h-index
- 304 i10-index 15,131
- Access
- Subscription · hybrid open access
- APC
- US$4,390 to publish open access
- ISSN
- 0033-3158, 1432-2072
- Country
- Germany
- Works published
- 18,513 cited 1,009,859 times
- Papers in 2025
- 252
- Field
- Neuroscience
- Website
- Journal home ↗
Psychopharmacology year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 225 | 23,272 |
| 2025 | 252 | 28,612 |
| 2024 | 219 | 30,601 |
| 2023 | 216 | 31,034 |
| 2022 | 271 | 31,249 |
| 2021 | 298 | 34,557 |
| 2020 | 306 | 38,312 |
| 2019 | 281 | 31,611 |
What Psychopharmacology publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Neurotransmitter Receptor Influence on BehaviorCellular and Molecular Neuroscience · 12,456 papers
- Neuroscience and Neuropharmacology ResearchCellular and Molecular Neuroscience · 5,758 papers
- Schizophrenia research and treatmentPsychiatry and Mental health · 3,138 papers
- Substance Abuse Treatment and OutcomesEpidemiology · 2,512 papers
- Treatment of Major DepressionPharmacology (medical) · 1,840 papers
Questions about Psychopharmacology
What is the impact factor of Psychopharmacology?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 4.17 for Psychopharmacology: on average, each paper it published in the two years before was cited about 4.17 times in a year.
What is the h-index of Psychopharmacology?
304, by OpenAlex's count: 304 of its papers have each been cited at least 304 times. Its i10-index is 15,131.
Is Psychopharmacology open access?
Not fully. Psychopharmacology is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the publication fee (APC) of Psychopharmacology?
About US$4,390, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Psychopharmacology?
Its linking ISSN is 0033-3158; all its ISSNs: 0033-3158, 1432-2072.
Who publishes Psychopharmacology?
Springer Science+Business Media, based in Germany.
How many papers does Psychopharmacology publish a year?
252 in 2025, by OpenAlex's count of what it published that year.
What does Psychopharmacology publish?
Its most frequent research topics are Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Schizophrenia research and treatment, in the field of Neuroscience.
Is Psychopharmacology a predatory journal?
Nothing in the scholarly indexes suggests so. Psychopharmacology is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 18,513 works cited 1,009,859 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Psychopharmacology indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (0033-3158): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Psychopharmacology
Other Neuroscience journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).